Home Newsfeeds Northcoast Research Downgrades Wendy’s to Neutral

Northcoast Research Downgrades Wendy’s to Neutral

Northcoast Research analyst Jim Sanderson downgrades Wendy's (NASDAQ:WEN) from Buy to Neutral.

byBenzinga Newsdesk

March 6, 2023

1 minute read

Northcoast Research analyst Jim Sanderson downgrades Wendy’s (NASDAQ:WEN) from Buy to Neutral.

FDA Adcomm Gives Thumbs Down To Amgen’s Lumakras For Advanced Form Of Lung Cancer

By Vandana Singh

October 6, 8:59 AM

FDA advisers concluded that the data from a late-stage trial lacked the requisite reliability to endorse the traditional approval of Amgen Inc's (NASDAQ: AMGN) Lumakras for patients afflicted with an advanced

AMGN

Trulieve Q1 FY23 Revenue Declines 9%, What About Net Loss?

By Vuk Zdinjak

May 10, 8:12 AM

Trulieve Cannabis Corp. (OTCQX: TCNNF) (CSE:TRUL) released its results for the quarter ended March 31, 2023, revealing revenue of $289 million, a decrease of 9% compared to $318 million in Q1 2022. Q1 2023 Financial Highlights

CSE:TRUL

Edward Jones Upgrades Activision Blizzard to Buy

By Benzinga Newsdesk

December 6, 8:28 AM

Edward Jones analyst Logan Purk upgrades Activision Blizzard (NASDAQ:ATVI) from Hold to Buy.

ATVI

Inspira Technologies Enters Into Collaboration Agreement With U.S.-Based Perfusion Solution Inc.; Collaboration Involves Combining The INSPIRA ART100 Product With Perfusion Solution’s Broad Commercial Footprint And Infrastructure Across The U.S.

By Happy Mohamed

July 19, 8:05 AM

Perfusion Solution, Inc. is a leading U.S.-based company that provides a platform of advanced medical devices, training and staffing to leading U.S. hospitals. RA'ANANA, Israel, July 19,

IINN

Northcoast Research Downgrades Wendy’s to Neutral

Related Posts

FDA Adcomm Gives Thumbs Down To Amgen’s Lumakras For Advanced Form Of Lung Cancer

Trulieve Q1 FY23 Revenue Declines 9%, What About Net Loss?

Edward Jones Upgrades Activision Blizzard to Buy

Inspira Technologies Enters Into Collaboration Agreement With U.S.-Based Perfusion Solution Inc.; Collaboration Involves Combining The INSPIRA ART100 Product With Perfusion Solution’s Broad Commercial Footprint And Infrastructure Across The U.S.